Shares of Cencora Inc. COR shed 1.73% to $283.95 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.09% to 6,005.88 and the Dow ...

CONSHOHOCKEN, Pa., May 28, 2025--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Lori J. Ryerkerk as a new independent director, effective June 1 ...

Shareholders might have noticed that Cencora, Inc. (NYSE:COR) filed its quarterly result this time last week. The early response was not positive, with shares down 3.1% to US$283 in the past week.

Charles Rhyee, an analyst from TD Cowen, reiterated the Buy rating on Cencora (COR – Research Report). The associated price target is $215.00. Charles Rhyee’s Buy rating for Cencora’s stock ...

In a report released today, Stephanie Davis from Barclays maintained a Buy rating on Cencora (COR – Research Report), with a price target of $263.00. The company’s shares closed yesterday at ...

May 7 (Reuters) - U.S. drug distributor Cencora (COR.N), opens new tab raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs.

CONSHOHOCKEN, PA — Cencora has significantly amplified its efforts to combat drug shortages through the expansion of its sure ...

For fiscal 2024, the Pennsylvania-based company projects its adjusted earnings per share to reach $13.60-$13.70 in diluted terms, up from its previous outlook of $13.55-$1.65, and compared to $13. ...

Cencora gets a buy rating, agreeing with today's consensus from Wall St. The sector and macro environment point to continued demand for the healthcare supplies and niche specialty drugs Cencora ...

July 31 (Reuters) - U.S. drug distributor Cencora (COR.N), opens new tab said on Wednesday that additional data on patients, beyond what was initially identified, had been stolen in a cyberattack ...

PharmaLex is now part of Cencora, a leading global pharmaceutical solutions organization centered on improving lives around the world. PharmaLex adds to Cencora’s expanding suite of pharma solutions ...